Galapagos NV
GLPG
#4540
Rank
โ‚น204.59 B
Marketcap
โ‚น3,105
Share price
-0.73%
Change (1 day)
55.96%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น31.08. In 2024 the company made an earnings per share (EPS) of โ‚น106.81 a decrease over its 2023 EPS that were of โ‚น325.19.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-132.46%
2024โ‚น106.81-67.16%
2023โ‚น325.19-199.64%
2022-โ‚น326.3699.03%
2021-โ‚น163.98-68.98%
2020-โ‚น528.64-298.06%
2019โ‚น266.91-554.64%
2018-โ‚น58.71-77.18%
2017-โ‚น257.30-326.21%
2016โ‚น113.74-134.19%
2015-โ‚น332.66-371.34%
2014โ‚น122.60-445.98%
2013-โ‚น35.4432.88%
2012-โ‚น26.67-82.07%
2011-โ‚น148.76-817.9%
2010โ‚น20.7212.73%
2009โ‚น18.38-120.79%
2008-โ‚น88.40-37.67%
2007-โ‚น141.8339.64%
2006-โ‚น101.5728.17%
2005-โ‚น79.256.25%
2004-โ‚น74.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น956.68-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น738.36-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น123.89-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น339.59-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น695.90-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น278.13-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น329.53-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น55.90 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น57.73-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel